113 related articles for article (PubMed ID: 24791856)
1. Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.
Theocharides AP; Dobson SM; Laurenti E; Notta F; Voisin V; Cheng PY; Yuan JS; Guidos CJ; Minden MD; Mullighan CG; Torlakovic E; Dick JE
Leukemia; 2015 Jan; 29(1):177-87. PubMed ID: 24791856
[TBL] [Abstract][Full Text] [Related]
2. TIF1β activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia.
Morii M; Kubota S; Iimori M; Yokomizo-Nakano T; Hamashima A; Bai J; Nishimura A; Tasaki M; Ando Y; Araki K; Sashida G
Leukemia; 2024 May; ():. PubMed ID: 38734786
[TBL] [Abstract][Full Text] [Related]
3. KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cells.
Ma L; Yin C; Zhang Y; Li J; Shi L; Zhou T; Huang X; Liu Y; Cao J; Wu G; Gu H; He L
Biol Chem; 2024 May; 405(5):341-349. PubMed ID: 38424700
[TBL] [Abstract][Full Text] [Related]
4. Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells.
Park SM; Miyamoto DK; Han GYQ; Chan M; Curnutt NM; Tran NL; Velleca A; Kim JH; Schurer A; Chang K; Xu W; Kharas MG; Woo CM
Cancer Cell; 2023 Apr; 41(4):726-739.e11. PubMed ID: 36898380
[TBL] [Abstract][Full Text] [Related]
5. Murine Models of Acute Myeloid Leukaemia.
Almosailleakh M; Schwaller J
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669675
[TBL] [Abstract][Full Text] [Related]
6. BCR::ABL1 fusion gene positive de novo acute myeloid leukemia with coexistence of NRAS mutation and presented with a peculiar CD58 positive immunophenotype.
Zhang X; Guo X
Cytometry B Clin Cytom; 2024 Mar; 106(2):146-148. PubMed ID: 37969054
[No Abstract] [Full Text] [Related]
7. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny.
Notta F; Zandi S; Takayama N; Dobson S; Gan OI; Wilson G; Kaufmann KB; McLeod J; Laurenti E; Dunant CF; McPherson JD; Stein LD; Dror Y; Dick JE
Science; 2016 Jan; 351(6269):aab2116. PubMed ID: 26541609
[TBL] [Abstract][Full Text] [Related]
8. Tumor archaeology: tracking leukemic evolution to its origins.
Dick JE
Sci Transl Med; 2014 May; 6(238):238fs23. PubMed ID: 24871129
[TBL] [Abstract][Full Text] [Related]
9. CDK6 levels regulate quiescence exit in human hematopoietic stem cells.
Laurenti E; Frelin C; Xie S; Ferrari R; Dunant CF; Zandi S; Neumann A; Plumb I; Doulatov S; Chen J; April C; Fan JB; Iscove N; Dick JE
Cell Stem Cell; 2015 Mar; 16(3):302-13. PubMed ID: 25704240
[TBL] [Abstract][Full Text] [Related]
10. Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression.
Beer PA; Knapp DJ; Miller PH; Kannan N; Sloma I; Heel K; Babovic S; Bulaeva E; Rabu G; Terry J; Druker BJ; Loriaux MM; Loeb KR; Radich JP; Erber WN; Eaves CJ
Blood; 2015 Jan; 125(3):504-15. PubMed ID: 25370416
[TBL] [Abstract][Full Text] [Related]
11. Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia.
Lana T; de Lorenzo P; Bresolin S; Bronzini I; den Boer ML; Cavé H; Froňková E; Stanulla M; Zaliova M; Harrison CJ; de Groot H; Valsecchi MG; Biondi A; Basso G; Cazzaniga G; te Kronnie G
Leukemia; 2015 Oct; 29(10):2107-10. PubMed ID: 25778098
[No Abstract] [Full Text] [Related]
12. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA
Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207
[TBL] [Abstract][Full Text] [Related]
13. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia.
Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA
Br J Haematol; 2015 Feb; 168(3):395-404. PubMed ID: 25312094
[TBL] [Abstract][Full Text] [Related]
14. Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment.
Yeung DT; Moulton DJ; Heatley SL; Nievergall E; Dang P; Braley J; Branford S; Moore S; Mullighan CG; Hughes TP; White DL
Leukemia; 2015 Jan; 29(1):230-2. PubMed ID: 25179732
[No Abstract] [Full Text] [Related]
15. Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.
Churchman ML; Low J; Qu C; Paietta EM; Kasper LH; Chang Y; Payne-Turner D; Althoff MJ; Song G; Chen SC; Ma J; Rusch M; McGoldrick D; Edmonson M; Gupta P; Wang YD; Caufield W; Freeman B; Li L; Panetta JC; Baker S; Yang YL; Roberts KG; McCastlain K; Iacobucci I; Peters JL; Centonze VE; Notta F; Dobson SM; Zandi S; Dick JE; Janke L; Peng J; Kodali K; Pagala V; Min J; Mayasundari A; Williams RT; Willman CL; Rowe J; Luger S; Dickins RA; Guy RK; Chen T; Mullighan CG
Cancer Cell; 2015 Sep; 28(3):343-56. PubMed ID: 26321221
[TBL] [Abstract][Full Text] [Related]
16. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine.
Hunger SP; Mullighan CG
Blood; 2015 Jun; 125(26):3977-87. PubMed ID: 25999453
[TBL] [Abstract][Full Text] [Related]
17. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.
Ma X; Edmonson M; Yergeau D; Muzny DM; Hampton OA; Rusch M; Song G; Easton J; Harvey RC; Wheeler DA; Ma J; Doddapaneni H; Vadodaria B; Wu G; Nagahawatte P; Carroll WL; Chen IM; Gastier-Foster JM; Relling MV; Smith MA; Devidas M; Guidry Auvil JM; Downing JR; Loh ML; Willman CL; Gerhard DS; Mullighan CG; Hunger SP; Zhang J
Nat Commun; 2015 Mar; 6():6604. PubMed ID: 25790293
[TBL] [Abstract][Full Text] [Related]
18. Whole-transcriptome analysis of endothelial to hematopoietic stem cell transition reveals a requirement for Gpr56 in HSC generation.
Solaimani Kartalaei P; Yamada-Inagawa T; Vink CS; de Pater E; van der Linden R; Marks-Bluth J; van der Sloot A; van den Hout M; Yokomizo T; van Schaick-Solernó ML; Delwel R; Pimanda JE; van IJcken WF; Dzierzak E
J Exp Med; 2015 Jan; 212(1):93-106. PubMed ID: 25547674
[TBL] [Abstract][Full Text] [Related]
19. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
[TBL] [Abstract][Full Text] [Related]
20. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
Berres ML; Lim KP; Peters T; Price J; Takizawa H; Salmon H; Idoyaga J; Ruzo A; Lupo PJ; Hicks MJ; Shih A; Simko SJ; Abhyankar H; Chakraborty R; Leboeuf M; Beltrão M; Lira SA; Heym KM; Clausen BE; Bigley V; Collin M; Manz MG; McClain K; Merad M; Allen CE
J Exp Med; 2015 Feb; 212(2):281. PubMed ID: 25646268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
